= CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS (“[*]”), HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24B-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED....And Inventions Agreement • February 7th, 2007 • Vaxgen Inc • Pharmaceutical preparations • Delaware
This letter sets forth the terms of the transition and separation agreement (the “Agreement”) that VaxGen, Inc. (the “Company” or “VaxGen”) is offering to you to aid in your employment transition.
CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS (“[*]”), HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24B-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED....Certain • February 7th, 2007 • Vaxgen Inc • Pharmaceutical preparations • Delaware
This letter sets forth the terms of the transition and separation agreement (the “Agreement”) that VaxGen, Inc. (the “Company” or “VaxGen”) is offering to you to aid in your employment transition.
CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS (“[*]”), HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24B-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED....Information and Inventions Agreement • February 7th, 2007 • Vaxgen Inc • Pharmaceutical preparations • Delaware
This letter sets forth the terms of the transition and separation agreement (the “Agreement”) that VaxGen, Inc. (the “Company” or “VaxGen”) is offering to you to aid in your employment transition.
